Dr. Henry’s Vitamins introduces Prenatal Plus and Omega-3 for Women

Dr.Henry’s Vitamins has revealed their latest products, the Prenatal Plus and Omega-3 for Women, which are claimed to be made with the purest ingredients so that the body absorbs them all. Dr.Henry’s Vitamins was founded by Dr. Henry Dunklau, a doctor of pharmacy with a passion to inspire and educate people about vitamins, supplements, essential More...

by pharmanewsdaily | Published 7 days ago
By pharmanewsdaily On Monday, February 11th, 2019
0 Comments

Samsung Bioepis, C-Bridge Capital collaborate to develop and commercialize biosimilars in China

Samsung Bioepis, a South Korean biopharma company, has signed a licensing agreement with private equity firm C-Bridge Capital to develop and commercialize next-generation biosimilars in China. The agreement covers More...

By pharmanewsdaily On Sunday, February 10th, 2019
0 Comments

Ablynx wins Cablivi FDA approval for rare blood clotting disorder

Cablivi FDA approval : Belgian biopharma company Ablynx has bagged approval from the US Food and Drug Administration (FDA) for its anti-vWF nanobody Cablivi (caplacizumab-yhdp) injection in combination with plasma More...

By pharmanewsdaily On Sunday, February 10th, 2019
0 Comments

Pulmatrix secures FDA approval for Pulmazole phase 2 clinical study

Pulmazole phase 2 clinical study : Pulmatrix said that the US Food and Drug Administration (FDA) has authorized the Massachusetts-based biopharma company to begin a phase 2 clinical trial for Pulmazole (PUR1900), More...

By pharmanewsdaily On Sunday, February 10th, 2019
0 Comments

GSK wraps up $5.1bn acquisition of US cancer drug company Tesaro

GSK acquisition of Tesaro : British pharma giant GlaxoSmithKline (GSK) has completed its previously announced $5.1 billion acquisition of Tesaro, an oncology-focused biopharma company based in Waltham, Massachusetts. The More...

By pharmanewsdaily On Sunday, February 10th, 2019
0 Comments

BridgeBio Pharma raises $299m to develop genetic disease drugs

BridgeBio Pharma, a clinical-stage biopharma company focused on the development of drugs for genetic diseases, raised $299.2 million in a new funding round. The California-based biopharma company said that it will More...

By pharmanewsdaily On Sunday, February 3rd, 2019
0 Comments

Newron completes patient enrollment for STARS clinical trial of sarizotan

Itaian pharma company Newron Pharmaceuticals has completed enrollment of patients in its STARS clinical trial of Sarizotan for the treatment of apneas in Rett Syndrome. Newron Pharmaceuticals is targeting to More...

By pharmanewsdaily On Sunday, February 3rd, 2019
0 Comments

Dr. Reddy’s appoints Marc Kikuchi as new head of generics business in North America

Dr. Reddy’s Laboratories has appointed Marc Kikuchi as CEO of its North America Generics unit. As part of the senior leadership team of Dr. Reddy’s Laboratories, Marc Kikuchi will undertake responsibility of More...

By pharmanewsdaily On Sunday, February 3rd, 2019
0 Comments

Pfizer lung cancer drug Vizimpro bags CHMP’s positive opinion

The Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Pfizer lung cancer drug Vizimpro (dacomitinib) 45 mg in Europe as monotherapy for the first-line treatment of adult patients More...

By pharmanewsdaily On Sunday, February 3rd, 2019
0 Comments

SIRION Biotech opens new office in Massachusetts

CAMBRIDGE, Mass.–(BUSINESS WIRE)–SIRION Biotech International Inc., a wholly-owned subsidiary of SIRION Biotech GmbH in Germany (“SIRION”), offering the most comprehensive portfolio of custom viral More...